BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2016

Sep 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2016-09-14

Reporting Person: Barnes Alane P (VP, General Counsel & Corp Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-14	Common Stock	S	8357	$4.27	Disposed	79377	Direct

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2016.

F2: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.22 to $4.31. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.